Galapagos NV | 90.36 |
Date/Time | 01/27 / 16:52 |
Chg. / Chg.(%) | - / |
Bid | 91.58 / 100 |
Ask | 91.84 / 100 |
Open | 90.36 |
Previous Close | 90.72 |
High | 90.36 |
Low | 90.36 |
Volume [EUR] | 9,849.24 |
Volume [Units] | 109 |
Price fixings | 1 |
ISIN | BE0003818359 |
Security | GLPG/A |
Exchange | Cboe Europe BXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - A.. | 88.42 | ![]() |
178,619 |
Cboe Europe .. | 88.42 | ![]() |
26,523 |
London Inter.. | 88.36 | ![]() |
10,308 |
Turquoise | 88.48 | ![]() |
8,517 |
TradeGate | 88.42 | ![]() |
356 |
gettex | 88.420 | ![]() |
59 |
Frankfurt | 89.9200 | ![]() |
2 |
Cboe Europe .. | 87.70 | ![]() |
1 |
Düsseldorf | 87.52 | ![]() |
0 |
München | 90.20 | ![]() |
0 |
Berlin | 88.32 | ![]() |
0 |
Vienna Globa.. | 88.84 | ![]() |
0 |
Lang & Schwa.. | 88.30 | ![]() |
|
Stuttgart | 87.720 | ![]() |
|
Cboe Europe .. | 90.36 | 109 | |
Nasdaq Other.. | 110.1000 | ![]() |
58 |
Xetra | 90.60 | 15 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
01/20/2021 / 08:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
01/07/2021 / 08:00 - GlobeNewswire - Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:30 - GlobeNewswire